Kalamazoo, MI, United States of America

Louis L Skaletzky


Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 94(Granted Patents)


Location History:

  • Parchment, MI (US) (1983)
  • Kalamazoo, MI (US) (1976 - 2001)

Company Filing History:


Years Active: 1976-2001

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Louis L. Skaletzky

Introduction

Louis L. Skaletzky is a notable inventor based in Kalamazoo, MI (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, he has made remarkable advancements in the treatment of various medical conditions.

Latest Patents

Among his latest patents, one includes compounds useful for treating retroviral infections. This invention relates to specific compounds, including pyran-2-ones and their derivatives, which are effective in inhibiting retroviruses in infected mammalian cells. Another notable patent involves bis-sulfonamides hydroxamic acids as matrix metalloproteinase (MMP) inhibitors. This invention provides compounds that are crucial in preventing tissue degradation by inhibiting MMPs.

Career Highlights

Throughout his career, Louis L. Skaletzky has worked with prominent companies such as The Upjohn Company and Pharmacia & Upjohn Company. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.

Collaborations

He has collaborated with several professionals in his field, including Karen Rene Romines and Gordon L. Bundy. These collaborations have further enhanced his research and development efforts.

Conclusion

Louis L. Skaletzky's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…